Prognostic significance of left ventricular hypertrophy observed at dialysis initiation depends on the pre-dialysis use of erythropoiesis-stimulating agents

• HAYASHI Terumasa

  Department of Kidney Disease and Hypertension, Osaka General Medical Center

• KIMURA Tomonori

  Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine

• YASUDA Keiko

  Department of Nephrology, Rinku General Medical Center

• OBI Yoshitsugu

  Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine

• SASAKI Koichi

  Department of Nephrology, Rinku General Medical Center

• IIO Kenichiro

  Department of Nephrology, National Hospital Organization, Osaka Minami Medical Center

• MIYASATO Kenro

  Department of Nephrology, National Hospital Organization, Osaka Minami Medical Center

• KAMIMURA Taro

  Matsuyama Red-Cross Hospital

• KITAMURA Harumi

  Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine

• TSUBAKIHARA Yoshiharu

  Department of Kidney Disease and Hypertension, Osaka General Medical Center

• RAKUGI Hiromi

  Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine

• ISAKA Yoshitaka

  Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine

収録刊行物

• Clinical and experimental nephrology

  Clinical and experimental nephrology 17 (2), 294-303, 2013-04-01

キーワード

• Anemia
• Chronic kidney disease
• Erythropoietin
• Left ventricular hypertrophy
• Prognosis
• Reverse epidemiology

詳細情報

• CRID: 1573105975993966464
• NII論文ID: 10031169479
• NII書誌ID: AA11126935
• ISSN: 13421751
• Web Site: https://search.jamas.or.jp/link/ui/2014215517
• 本文言語コード: en
• データソース種別:
  • CiNii Articles